Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation

[1]  Y. Okazaki,et al.  Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT–PCR , 2004, British Journal of Cancer.

[2]  K. Ang,et al.  Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors. , 2004, International journal of radiation oncology, biology, physics.

[3]  Y. Hayashizaki,et al.  Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites , 2002, British Journal of Cancer.

[4]  Masahiko Miura,et al.  Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy. , 2002, Cancer research.

[5]  C. Galmarini,et al.  In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia , 2002, British journal of haematology.

[6]  Hoyun Lee,et al.  The Generation and Characterization of a Radiation-Resistant Model System to Study Radioresistance in Human Breast Cancer Cells , 2001, Radiation research.

[7]  H. Choy,et al.  A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  J. Inazawa,et al.  Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. , 2001, Cancer research.

[9]  S. Srinivasula,et al.  Regulation of IL-1β generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins , 2001, Cell Death and Differentiation.

[10]  D. Shrieve,et al.  A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. , 2001, Cancer research.

[11]  K. Kadota,et al.  Preprocessing implementation for microarray (PRIM): an efficient method for processing cDNA microarray data. , 2001, Physiological genomics.

[12]  Vishva M Dixit,et al.  ICEBERG A Novel Inhibitor of Interleukin-1β Generation , 2000, Cell.

[13]  Y. Doki,et al.  Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  J. Little,et al.  Response of human tumor cells of varying radiosensitivity and radiocurability to fractionated irradiation. , 1999, Cancer research.

[15]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[16]  E. Markakis,et al.  Expression of CD 73 (ecto-5'-nucleotidase) in 165 glioblastomas by immunohistochemistry and electronmicroscopic histochemistry. , 1999, Anticancer research.

[17]  T. Kawaguchi,et al.  Expression of cyclooxygenase‐2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation , 1999, Hepatology.

[18]  T. Fahey,et al.  Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. , 1999, Cancer research.

[19]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Borkowski,et al.  bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. , 1998, Urology.

[21]  Y. Yatabe,et al.  Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. , 1998, Cancer research.

[22]  S. Meltzer,et al.  Advances in Brief Increased Expression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Barrett ' s Esophagus and Associated Adenocarcinomas 1 , 2006 .

[23]  T. Akimoto,et al.  Effect of radiation on the expression of E-cadherin and alpha-catenin and invasive capacity in human lung cancer cell line in vitro. , 1998, International journal of radiation oncology, biology, physics.

[24]  D. Scollard,et al.  Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. , 1998, Journal of the National Cancer Institute.

[25]  Y. Matsumura,et al.  Increase in radiation sensitivity of human malignant melanoma cells by expression of wild-type p16 gene. , 1997, Cancer letters.

[26]  V. Tse,et al.  Functional expression of human p21(WAF1/CIP1) gene in rat glioma cells suppresses tumor growth in vivo and induces radiosensitivity. , 1997, Biochemical and biophysical research communications.

[27]  A. Ristimäki,et al.  Expression of cyclooxygenase-2 in human gastric carcinoma. , 1997, Cancer research.

[28]  R. Muschel,et al.  Potential molecular targets for manipulating the radiation response. , 1997, International journal of radiation oncology, biology, physics.

[29]  L. Milas,et al.  Programmed cell death and radioresistance , 1996, Cancer and Metastasis Reviews.

[30]  C. Coleman,et al.  Biologic basis for radiation oncology. , 1996, Oncology.

[31]  John Calvin Reed,et al.  Gamma-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. , 1996, Oncogene.

[32]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.

[33]  T. Wheldon,et al.  A radioresistant variant derived from a human neuroblastoma cell line is less prone to radiation-induced apoptosis. , 1995, Cancer research.

[34]  E. Brambilla,et al.  Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance. , 1995, European journal of cancer. Part B, Oral oncology.

[35]  C C Ling,et al.  Radiation-induced apoptosis: relevance to radiotherapy. , 1995, International journal of radiation oncology, biology, physics.

[36]  M. Weller,et al.  Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. , 1995, The Journal of clinical investigation.

[37]  T. Maniatis,et al.  NF-κB: A lesson in family values , 1995, Cell.

[38]  P Boracchi,et al.  Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[39]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[40]  P. May,et al.  Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. , 1994, Cancer research.

[41]  J. Wharton,et al.  The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. , 1994, International journal of radiation oncology, biology, physics.

[42]  D. Brachman,et al.  p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. , 1993, Cancer research.

[43]  Y. Doki,et al.  Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line. , 1993, Cancer research.

[44]  M. Imamura,et al.  Characterization of 21 newly established esophageal cancer cell lines , 1992, Cancer.

[45]  M. Sklar.  The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. , 1988, Science.

[46]  R. Weichselbaum,et al.  The raf oncogene is associated with a radiation-resistant human laryngeal cancer. , 1987, Science.

[47]  S. Wolff,et al.  Adaptive response of human lymphocytes to low concentrations of radioactive thymidine. , 1984, Science.

[48]  J. Fowler,et al.  The effect of low-dose pre-operative X-irradiation of implanted mouse mammary carcinomas on local recurrence and metastasis. , 1976, British Journal of Cancer.

[49]  W. K. Sinclair,et al.  X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. , 1966, Radiation research.

[50]  T. Kuroki,et al.  Molecular and cellular features of esophageal cancer cells , 2005, Journal of Cancer Research and Clinical Oncology.

[51]  辰巳 陽一.  Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines , 2004 .

[52]  Yusuke Nakamura,et al.  Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. , 2002, Neoplasia.

[53]  K. Kashima,et al.  Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines , 2002, Journal of Gastroenterology.

[54]  V. Dixit,et al.  ICEBERG: a novel inhibitor of interleukin-1beta generation. , 2000, Cell.

[55]  S. Kitano,et al.  Increased expression , 2000 .

[56]  K. Schrör,et al.  Cyclooxygenase-2 expression in human esophageal carcinoma. , 1999, Cancer research.

[57]  秋元 哲夫.  Effect of radiation on the expression of E-cadherin and α-catenin and invasive capacity in human lung cancer cell line in vitro , 1998 .

[58]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[59]  Y. Doki,et al.  E-Cadherin and α-Catenin Expression in Human Esophageal Cancer , 1994 .

[60]  T. Westfall,et al.  ALTERATIONS IN THE , 1985 .